The deal passed every BANT check. Budget was approved. The contact was a vice president. The need was clear, and the timeline was set for next quarter.
Four months later, the deal died. Not to a competitor, but to “no decision.” The team decided to keep doing what they were already doing.
BANT didn’t fail because it asked the wrong questions. It failed because it skipped the ones that matter most. This guide looks at the best BANT alternatives, and the human questions every qualification framework should add.
What BANT Still Gets Right
BANT (budget, authority, need, and timing) has lasted for decades for good reasons. It’s simple, easy to teach, and quick to apply. It also filters out many accounts that were never going to buy.
For the basics, see our guide to the BANT framework. The problem isn’t that BANT is wrong. It’s that it assumes a rational, single buyer making a clean decision.
What BANT Misses
Real B2B decisions are made by groups of people, each with their own risks and doubts. Forrester’s State of Business Buying 2024 found that 86% of B2B purchases stall at some point in the process.
Many of those stalls come from factors BANT doesn’t ask about:
| BANT asks | What often decides the deal |
|---|---|
| Is there budget? | Is anyone willing to spend it on this, rather than something else? |
| Who has authority? | Who can quietly block the decision? |
| Is there a need? | Does the group agree the problem is worth solving now? |
| When is the timeline? | Does the champion feel confident enough to push it forward? |
The right column is harder to measure. It’s also where most deals are won or lost.
B2B Buying Is More Personal Than It Looks
Research backs this up. A study by CEB and Google, From Promotion to Emotion, found that personal value, such as professional reputation and confidence, had twice the impact of business value on B2B purchase decisions. Buyers who saw personal value were also far more likely to pay a premium.
That study dates from 2013, yet later research points the same way. Gartner found that B2B buyers who felt confident in their decision-making were 2.6 times more likely to buy more.
The reason is simple. In B2B, a bad purchase can damage a career. So buyers weigh personal risk alongside business benefit, even if they never say so out loud.
BANT Alternatives Compared
Several frameworks try to fix BANT’s gaps. Each has strengths and blind spots.
| Framework | What it stands for | Best for | Blind spot |
|---|---|---|---|
| BANT | Budget, Authority, Need, Timing | Fast, early filtering | Assumes one rational buyer |
| CHAMP | Challenges, Authority, Money, Prioritization | Leading with the buyer’s problem | Still light on group dynamics |
| MEDDIC | Metrics, Economic buyer, Decision criteria, Decision process, Identify pain, Champion | Complex, high-value deals | Can feel heavy for smaller deals |
| MEDDPICC | MEDDIC plus Paper process and Competition | Enterprise deals with procurement | Takes time and discipline |
| GPCTBA/C&I | Goals, Plans, Challenges, Timeline, Budget, Authority, Negative consequences, Positive implications | Consultative, goal-based selling | Long to run in full |
MEDDIC and its variations come closest to how groups really buy, because they cover the decision process and the champion. Still, none of these frameworks directly asks how confident or at-risk the buyer feels.
Add Three Human Questions to Any Framework
Whatever framework you use, add these three questions. They catch the risks that most often lead to “no decision.”
| Question | Why it matters | How to ask it |
|---|---|---|
| Confidence: Does the champion feel able to make and defend this decision? | Unsure champions stall deals, even with budget | “What would you need to feel comfortable taking this to your leadership?” |
| Personal stakes: What does success or failure mean for them? | Personal risk shapes every decision | “If this goes well, what changes for you and your team?” |
| Consensus: Does the wider group agree the problem matters now? | Disagreement is a leading cause of stalls | “Who else needs to agree this is a priority, and do they yet?” |
Ask these conversationally, not as a checklist. The goal is to understand the buyer, not to score them. This approach also works well in early calls, as covered in our guide to B2B appointment setting.
Spot “No Decision” Risk Early
Deals that end in “no decision” usually show warning signs weeks in advance:
- The problem is described differently by each person you speak to.
- The champion avoids involving senior leaders.
- New stakeholders keep joining and reopening earlier discussions.
- Nobody can explain what happens if the company does nothing.
- The champion talks about the project but not about their own role in it.
When you see these signs, slow down and help the group align before pushing for a decision. Often, that means reaching more of the buying committee. Our guides to buying committee mapping and single-threaded ABM explain how.
A Hybrid Qualification Scorecard
You don’t need to pick one framework. Combine the most useful parts into a short scorecard:
| Criterion | Borrowed from | Score 0–2 |
|---|---|---|
| Clear problem or challenge | CHAMP | |
| Access to the economic buyer | MEDDIC | |
| Known decision process | MEDDIC | |
| Realistic timing | BANT | |
| Champion confidence | Human questions | |
| Group agreement on the problem | Human questions | |
| Clear personal win for the champion | Human questions |
Score each criterion from 0 (unknown or negative) to 2 (confirmed). As a starting point, many teams treat 10 or more out of 14 as strong, and anything below 7 as a deal that needs more work before forecasting.
The gaps matter as much as the total. A deal can score well overall and still fail if champion confidence or group agreement is zero.
Where This Fits in the Wider Process
Qualification works best when it covers the whole account, not just one contact. That starts with how leads reach sales, as covered in our piece on the MQL to SQL handoff, and continues through every stage of the deal. For more on what makes an SQL, see our guide to sales-qualified leads.
The Short Version
BANT tells you whether a deal is possible. It doesn’t tell you whether the people involved feel ready to make it happen.
Keep what works in BANT, borrow the best of MEDDIC and CHAMP, and add three human questions about confidence, personal stakes, and consensus. That’s how you qualify for the way B2B decisions are actually made.
Losing deals to “no decision”?
ColedaB2B helps B2B teams build qualification that reflects how buying groups really decide, from first handoff to forecast. Talk to us about your pipeline.
FAQs:
Popular alternatives include CHAMP, MEDDIC, MEDDPICC, and GPCTBA/C&I. MEDDIC and MEDDPICC suit complex deals, while CHAMP works well when you want to lead with the buyer’s challenges.
Yes, for fast early filtering. However, it assumes a single, rational buyer, so it works best combined with questions about the decision process, the champion, and group agreement.
BANT checks budget, authority, need, and timing. MEDDIC goes deeper, covering metrics, the economic buyer, decision criteria, decision process, pain, and the champion.
Deals often stall because the buying group doesn’t agree on the problem, the champion lacks confidence, or new stakeholders keep reopening discussions. Forrester found that 86% of B2B purchases stall at some point.
Yes. CEB and Google research found that personal value, such as reputation and confidence, had twice the impact of business value on B2B purchase decisions.
